KE3427A - Long-acting parenteral compositions of haloperidol and bromoperidol derivatives - Google Patents
Long-acting parenteral compositions of haloperidol and bromoperidol derivativesInfo
- Publication number
- KE3427A KE3427A KE3427A KE342784A KE3427A KE 3427 A KE3427 A KE 3427A KE 3427 A KE3427 A KE 3427A KE 342784 A KE342784 A KE 342784A KE 3427 A KE3427 A KE 3427A
- Authority
- KE
- Kenya
- Prior art keywords
- bromoperidol
- haloperidol
- derivatives
- long
- parenteral compositions
- Prior art date
Links
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical group C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 title 2
- RKLNONIVDFXQRX-UHFFFAOYSA-N Bromperidol Chemical class C1CC(O)(C=2C=CC(Br)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 RKLNONIVDFXQRX-UHFFFAOYSA-N 0.000 title 1
- 229960003878 haloperidol Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8082679A JPS568318A (en) | 1979-06-28 | 1979-06-28 | Non oral long acting composition of haloperidol and bromperidol derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KE3427A true KE3427A (en) | 1984-08-10 |
Family
ID=13729223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KE3427A KE3427A (en) | 1979-06-28 | 1984-07-20 | Long-acting parenteral compositions of haloperidol and bromoperidol derivatives |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS568318A (OSRAM) |
| BE (1) | BE883994A (OSRAM) |
| CY (1) | CY1255A (OSRAM) |
| DE (1) | DE3024305A1 (OSRAM) |
| FR (1) | FR2460932A1 (OSRAM) |
| GB (1) | GB2054371B (OSRAM) |
| HK (1) | HK83384A (OSRAM) |
| KE (1) | KE3427A (OSRAM) |
| NL (1) | NL190775C (OSRAM) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8621892D0 (en) * | 1986-09-11 | 1986-10-15 | Lundbeck & Co As H | Organic compound |
| DK238190D0 (da) * | 1990-10-03 | 1990-10-03 | Lundbeck & Co As H | Depotderivater |
| DK0669128T3 (da) * | 1992-11-17 | 2000-06-19 | Yoshitomi Pharmaceutical | Sustained-release mikrosfære indeholdende antipsykotikum og fremgangsmåde til at fremstille samme |
| CA2269328A1 (en) * | 1996-10-31 | 1998-05-07 | Richard B. Rothman | Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use as noncompetitive antagonists of dopamine reuptake |
| RU2178297C1 (ru) * | 2001-02-02 | 2002-01-20 | Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" | Фармацевтическая композиция, обладающая антипсихотическим и противорвотным действием, и способ ее получения |
| BRPI0517701A8 (pt) | 2004-11-10 | 2018-01-23 | Genzyme Corp | métodos de tratamento de diabetes mellitus |
| ES2546181T3 (es) | 2006-05-09 | 2015-09-21 | Genzyme Corporation | Métodos de tratar la enfermedad del hígado graso mediante inhibición de la síntesis de glucoesfingolípidos |
| EP2594563B1 (en) | 2007-05-31 | 2018-07-18 | Genzyme Corporation | 2-acylaminopropanol-type glucosylceramide synthase inhibitors |
| CA2701649C (en) | 2007-10-05 | 2016-05-24 | Genzyme Corporation | Method of treating polycystic kidney diseases with ceramide derivatives |
| CA2731685A1 (en) | 2008-07-28 | 2010-02-04 | Genzyme Corporation | Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease |
| CN102271678B (zh) | 2008-10-03 | 2017-06-30 | 简詹姆公司 | 2‑酰胺基丙醇型葡糖神经酰胺合成酶抑制剂 |
| EP3156056B1 (en) | 2011-03-18 | 2023-12-06 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions comprising sorbitan esters |
| CN103301461B (zh) * | 2012-03-08 | 2018-09-07 | 江苏豪森药业集团有限公司 | 一种长效注射制剂及其制备方法和用途 |
| AU2013235526B2 (en) | 2012-03-19 | 2017-11-30 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions comprising benzyl alcohol |
| AU2013235523B9 (en) | 2012-03-19 | 2018-01-04 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions comprising glycerol esters |
| CA2867121C (en) | 2012-03-19 | 2021-05-25 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions comprising fatty acid esters |
| ES2792149T3 (es) | 2012-09-19 | 2020-11-10 | Alkermes Pharma Ireland Ltd | Composiciones farmacéuticas que tienen estabilidad de almacenamiento mejorada |
| AU2015231278B2 (en) | 2014-03-20 | 2020-01-23 | Alkermes Pharma Ireland Limited | Aripiprazole formulations having increased injection speeds |
| CA3092335A1 (en) | 2018-03-05 | 2019-09-12 | Alkermes Pharma Ireland Limited | Aripiprazole dosing strategy |
| CN113117092A (zh) * | 2020-01-14 | 2021-07-16 | 中国科学院上海药物研究所 | 一种非水缓释递药系统 |
| HUP2100259A1 (hu) | 2021-07-07 | 2023-01-28 | Richter Gedeon Nyrt | Cariprazine tartalmú szabályozott hatóanyag-leadású injekciós készítmények |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3408356A (en) * | 1965-08-31 | 1968-10-29 | Squibb & Sons Inc | Long chain esters of 4'-fluoro-4-[4-hydroxy-4-(alpha, alpha, alpha-trifluorotolyl)piperi-dino]butyrophenone and the like |
| DE1695194A1 (de) * | 1966-07-11 | 1971-03-18 | Hoffmann La Roche | Verfahren zur Herstellung von Piperidinderivaten |
| US3850935A (en) * | 1971-10-16 | 1974-11-26 | Sumitomo Chemical Co | Process for producing piperidine derivatives by degrading quaternary piperidinium salts |
-
1979
- 1979-06-28 JP JP8082679A patent/JPS568318A/ja active Pending
-
1980
- 1980-06-03 GB GB8018117A patent/GB2054371B/en not_active Expired
- 1980-06-03 CY CY1255A patent/CY1255A/en unknown
- 1980-06-20 NL NL8003583A patent/NL190775C/xx not_active IP Right Cessation
- 1980-06-25 BE BE0/201165A patent/BE883994A/fr not_active IP Right Cessation
- 1980-06-27 DE DE19803024305 patent/DE3024305A1/de active Granted
- 1980-06-27 FR FR8014443A patent/FR2460932A1/fr active Granted
-
1984
- 1984-07-20 KE KE3427A patent/KE3427A/xx unknown
- 1984-11-01 HK HK833/84A patent/HK83384A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NL190775C (nl) | 1994-08-16 |
| NL8003583A (nl) | 1980-12-30 |
| DE3024305A1 (de) | 1981-01-22 |
| FR2460932A1 (fr) | 1981-01-30 |
| HK83384A (en) | 1984-11-09 |
| DE3024305C2 (OSRAM) | 1989-12-07 |
| GB2054371B (en) | 1983-08-03 |
| NL190775B (nl) | 1994-03-16 |
| BE883994A (fr) | 1980-12-29 |
| GB2054371A (en) | 1981-02-18 |
| JPS568318A (en) | 1981-01-28 |
| CY1255A (en) | 1984-08-31 |
| FR2460932B1 (OSRAM) | 1984-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KE3427A (en) | Long-acting parenteral compositions of haloperidol and bromoperidol derivatives | |
| NZ192653A (en) | 4-substituted piperidino-alkanol derivatives and pharmaceutical compositions containing them | |
| AU536181B2 (en) | Derivatives of camptothecin | |
| PH17391A (en) | Triazolthioalkyl substituted pleuromuilin derivatives and compositions thereof | |
| IL51865A0 (en) | New fluoroacylresorcin derivatives their preparation and compositions containing them | |
| NZ193798A (en) | 3-thiovinyl-cephalosporin derivatives and pharmaceutical compositions | |
| IL55555A0 (en) | Novel 3-phenyl-azacycloalkane derivatives and their preparation | |
| NZ187272A (en) | Alkylenediamine derivatives and pharmaceutical compositions | |
| IL60139A0 (en) | Novel 3-vinyl-cephalosporin derivatives and their preparation | |
| NZ194348A (en) | Fluorinated methyl-beta-alanine derivatives and pharmaceutical compositions | |
| GB2042892B (en) | Compositions of dispersability and preparation thereof | |
| NZ186335A (en) | Oxadizolopyrimidine derivatives and pharmazeutical compositions | |
| GB2050349B (en) | Isonicotinoyl derivatives of aminoacids | |
| GB2051794B (en) | Hydroxyamino-eburnane derivatives their preparation and use pharmalceutical compositions containing them and intermediates therefor | |
| DE3064789D1 (en) | New 25-hydroxy-24-oxocholestane derivatives and preparation thereof | |
| PT71537A (en) | Compositions of matter | |
| GB2055370B (en) | Ergol-8-ene and ergoline derivatives | |
| NZ193557A (en) | 4-phenylchroman derivatives intermediates and pharmaceutical compositions | |
| JPS5371042A (en) | Preparation of styrenized diphenylamine | |
| PH15451A (en) | Benzothiazole derivatives and compositions containing same | |
| GB2001980B (en) | Dioxazocine derivatives their preparation and compositions containing them | |
| JPS5639067A (en) | Pyrrolidineedione derivatives and mildewcidal composition containing them | |
| GB2044258B (en) | Quinoline derivatives useful as antioxidants their preparation and compositions containing them | |
| NZ185779A (en) | Derivatives of ortho-aminoacetophenone and pharaceutical compositions | |
| GB2041915B (en) | Preparation of bromo-p-terphenyl derivatives |